XGES.L vs. XNNS.L

Last updated Jun 5, 2026

XGES.L (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) and XNNS.L (Xtrackers MSCI Innovation UCITS ETF 1C) are both exchange-traded funds - XGES.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while XNNS.L is a Technology Equities fund tracking the MSCI World/Information Tech NR USD. Both are passively managed. A 0.69 correlation means they provide meaningful diversification when combined. Both charge a 0.35% expense ratio.

Performance

XGES.L vs. XNNS.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and Xtrackers MSCI Innovation UCITS ETF 1C (XNNS.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

XGES.L

• 1D: 4.22%
• 1M: 6.75%
• YTD: -0.81%
• 6M: -4.42%
• 1Y: 26.00%
• 3Y*: 1.51%
• 5Y*: —
• 10Y*: —

XNNS.L

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XGES.L vs. XNNS.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	-0.81%	11.22%	-1.38%	-7.92%	-8.46%
XNNS.L Xtrackers MSCI Innovation UCITS ETF 1C	-7.92%	6.27%	24.09%	26.71%	-12.09%

Correlation

The correlation between XGES.L and XNNS.L is 0.61, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.61
Correlation (3Y) Calculated over the trailing 3-year period	0.64
Correlation (All Time) Calculated using the full available price history since Jul 21, 2022	0.69

The correlation between XGES.L and XNNS.L has been stable across timeframes, ranging from 0.61 to 0.69 - a consistent structural relationship.

Return for Risk

XGES.L vs. XNNS.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XGES.L

XGES.L Risk / Return Rank: 37
XGES.L Sharpe Ratio Rank: 42
XGES.L Sortino Ratio Rank: 43
XGES.L Omega Ratio Rank: 38
XGES.L Calmar Ratio Rank: 35
XGES.L Martin Ratio Rank: 29

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XGES.L vs. XNNS.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and Xtrackers MSCI Innovation UCITS ETF 1C (XNNS.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XGES.L	XNNS.L	Difference
Sharpe ratio: Return per unit of total volatility	1.45	—	—
Sortino ratio: Return per unit of downside risk	2.15	—	—
Omega ratio: Gain probability vs. loss probability	1.25	—	—
Calmar ratio: Return relative to maximum drawdown	1.69	—	—
Martin ratio: Return relative to average drawdown	4.09	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	XGES.L	XNNS.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.45	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.12	—	—

Drawdowns

Drawdown Indicators

	XGES.L	XNNS.L	Difference
Max Drawdown Largest peak-to-trough decline	-35.79%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-15.29%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-25.52%	—	—
Current Drawdown Current decline from peak	-12.59%	—	—
Average Drawdown Average peak-to-trough decline	-17.98%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	6.34%	—	—

Volatility

Volatility by Period

	XGES.L	XNNS.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.45%	—	—
Volatility (6M) Calculated over the trailing 6-month period	13.62%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	17.84%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.27%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.27%	—	—

XGES.L vs. XNNS.L - Expense Ratio Comparison

Both XGES.L and XNNS.L have an expense ratio of 0.35%.

Dividends

XGES.L vs. XNNS.L - Dividend Comparison

Neither XGES.L nor XNNS.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both XGES.L and XNNS.L in my portfolio?

XGES.L and XNNS.L have a correlation of 0.61, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, XGES.L or XNNS.L?

Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, XGES.L or XNNS.L?

XGES.L and XNNS.L have the same expense ratio: 0.35% per year.

What is the main difference between XGES.L and XNNS.L?

XGES.L is categorized as Health & Biotech Equities, while XNNS.L is Technology Equities. XGES.L tracks MSCI World/Health Care NR USD, while XNNS.L tracks MSCI World/Information Tech NR USD.